BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38309029)

  • 1. Short-term survival analysis of a risk-adjusted model for ovarian cancer care.
    Hari A; Chang J; Villanueva C; Ziogas A; Vieira V; Bristow RE
    Gynecol Oncol; 2024 Feb; 184():123-131. PubMed ID: 38309029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Risk-Adjusted Model for Ovarian Cancer Care and Disparities in Access to High-Performing Hospitals.
    Bristow RE; Chang J; Villanueva C; Ziogas A; Vieira VM
    Obstet Gynecol; 2020 Feb; 135(2):328-339. PubMed ID: 31923082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.
    Galvan-Turner VB; Chang J; Ziogas A; Bristow RE
    Gynecol Oncol; 2015 Dec; 139(3):495-9. PubMed ID: 26387962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
    Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
    Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
    Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
    J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for laryngeal cancer.
    Swegal WC; Herbert RJ; Eisele DW; Chang J; Bristow RE; Gourin CG
    Laryngoscope; 2020 Mar; 130(3):672-678. PubMed ID: 31169916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm.
    Bristow RE; Palis BE; Chi DS; Cliby WA
    Gynecol Oncol; 2010 Sep; 118(3):262-7. PubMed ID: 20573392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease.
    Bristow RE; Chang J; Ziogas A; Randall LM; Anton-Culver H
    Gynecol Oncol; 2014 Feb; 132(2):403-10. PubMed ID: 24361578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.
    Bristow RE; Chang J; Ziogas A; Anton-Culver H; Vieira VM
    Gynecol Oncol; 2014 Jul; 134(1):60-7. PubMed ID: 24680770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
    Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
    Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
    Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
    J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
    Bristow RE; Chang J; Ziogas A; Anton-Culver H
    Obstet Gynecol; 2013 Jun; 121(6):1226-1234. PubMed ID: 23812456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
    Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
    J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California.
    Pfaendler KS; Chang J; Ziogas A; Bristow RE; Penner KR
    Obstet Gynecol; 2018 May; 131(5):899-908. PubMed ID: 29630020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.
    Bandera EV; Lee VS; Rodriguez-Rodriguez L; Powell CB; Kushi LH
    JAMA Oncol; 2015 Sep; 1(6):737-45. PubMed ID: 26181758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes of epithelial ovarian cancer treated at a tertiary-level hospital in India.
    Chandy RG; Thomas V; Sebastian A; Mani T; Thomas A; Joel A; Ram TS; Peedicayil A
    Indian J Cancer; 2023 Oct; 60(4):475-485. PubMed ID: 38185864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial Disparities in Survival Outcomes of Patients With Serous Epithelial Ovarian Cancer: A Retrospective Cohort Analysis.
    Shingala K; Stavros S; Parag S; Tercek A; Makhani SS; Bouz A; Galbo A; Chung-Bridges K
    Cureus; 2023 Jan; 15(1):e34389. PubMed ID: 36874646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.